Models
CAPLIN POINT LAB LTD.CAPLIPOINTPharmaceuticals & Biotechnology
₹1,361per share · Base Model Note
Revenue growth, the horizon and scenarios are yours to change. Every other input is part of the Trader plan; saving, sharing a saved link and the live-formula workbook are part of the Institutional plan.
Scenario
Value per share, your model₹1,361implied FY26 P/E 15.5× · EV/EBITDA 13.5×
Against CMP ₹2,752.60−50.6%close of 2026-09-10
Growth the CMP implies45.0%revenue, a year for 5 years, on your other inputs
Value after FY3181%share of enterprise value in the terminal
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.
Where the methods land · ₹ per share · the dashed line is the CMP
DCF, rate ±1 · growth ±1your model across the sensitivity grid
₹1,039₹2,004
52-week rangetraded range, a fact not a value
₹1,500₹2,877
From enterprise to equity · ₹ crore
| PV of FY27–FY31 free cash flow | 1,967 |
| PV of terminal value | 8,280 |
| Enterprise value | 10,247 |
| less net debt | 94 |
| less non-controlling interest | 0 |
| add non-operating investments | 0 |
| Equity value | 10,341 |
| ÷ 7.60 crore shares | ₹1,361 |
81% of the value sits after FY31. Usual when return on capital sits near the cost of capital; the 5 explicit years carry little of it.
Free cash flow, filed and modelled · ₹ '000 crore
Filed, cash from operations − capexModelled free cash flow to firm
Sensitivity · ₹ per share
Down Across| WACC ↓terminal growth → | 4.0% | 4.5% | 5.0% | 5.5% | 6.0% |
|---|---|---|---|---|---|
| 10.00% | 1,407 | 1,515 | 1,646 | 1,805 | 2,004 |
| 10.50% | 1,293 | 1,384 | 1,490 | 1,618 | 1,774 |
| 11.00% | 1,196 | 1,272 | 1,361 | 1,465 | 1,591 |
| 11.50% | 1,112 | 1,177 | 1,251 | 1,338 | 1,441 |
| 12.00% | 1,039 | 1,094 | 1,158 | 1,231 | 1,317 |
The outlined cell is your model. Green figures sit above the CMP of ₹2,752.60; n/a marks a terminal growth at or above the discount rate. Steps: WACC and terminal growth ±0.5 point, growth ±2, margin ±1.
Distribution of outcomes · 4,000 draws · growth, margin and the discount rate vary together
| 10th · 50th · 90th percentile, ₹ per share | 1,097 · 1,349 · 1,657 |
| Draws below the CMP | 100% |
| Rank correlation with ebitda margin | +0.69 |
| Rank correlation with discount rate | −0.60 |
| Rank correlation with revenue growth | +0.33 |
Each driver is drawn from a PERT distribution between the lowest and highest value across your scenarios (or ±50% growth, ±20% margin when there is one scenario), with the discount rate ±1.5 points. Seeded, so the same inputs give the same picture.
Projected cash flow to the firm · ₹ crore
History Forward| ₹ crore | FY23 | FY24 | FY25 | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,467 | 1,694 | 1,937 | 2,187 | 2,472 | 2,793 | 3,156 | 3,566 | 4,030 |
| growth % | 15.5 | 15.5 | 14.4 | 12.9 | 13.0 | 13.0 | 13.0 | 13.0 | 13.0 |
| EBITDA | 441 | 552 | 647 | 761 | 860 | 972 | 1,098 | 1,241 | 1,402 |
| margin % | 30.1 | 32.6 | 33.4 | 34.8 | 34.8 | 34.8 | 34.8 | 34.8 | 34.8 |
| less depreciation | (45) | (53) | (66) | (73) | (82) | (92) | (104) | (118) | (133) |
| EBIT | 396 | 498 | 581 | 688 | 779 | 880 | 994 | 1,123 | 1,269 |
| less tax on EBIT | (131) | (149) | (168) | (190) | (215) | (242) | |||
| NOPAT | 557 | 630 | 712 | 804 | 909 | 1,027 | |||
| add depreciation | 45 | 53 | 66 | 73 | 82 | 92 | 104 | 118 | 133 |
| less capex | (194) | (146) | (192) | (248) | (279) | (264) | (241) | (207) | (160) |
| less working-capital build | — | (125) | (141) | (159) | (180) | (203) | |||
| Free cash flow to firm | 78 | 165 | 241 | — | 308 | 399 | 509 | 640 | 797 |
| Discount factor | 0.949 | 0.855 | 0.770 | 0.694 | 0.625 | ||||
| Present value | 292 | 341 | 392 | 444 | 498 |
History columns are the filed years (free cash flow there is cash from operations − capex, as filed); the base year and everything to its right come from the engine. Forward is the explicit horizon of the model itself: 3, 5 or 10 years, then flat.
The three statements, projected · ₹ crore · debt held at 1, dividends at 7.1% of profit
| ₹ crore | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| EBIT | 688 | 779 | 880 | 994 | 1,123 | 1,269 |
| Interest at 8% on debt | (0) | (0) | (0) | (0) | (0) | |
| Profit before tax | 778 | 880 | 994 | 1,123 | 1,269 | |
| Profit after tax | 641 | 630 | 712 | 804 | 909 | 1,027 |
| Dividends | (46) | (45) | (51) | (57) | (65) | (73) |
| Balance sheet, year end | ||||||
| Cash | 94 | 357 | 705 | 1,157 | 1,732 | 2,457 |
| Working capital | 959 | 1,083 | 1,224 | 1,383 | 1,563 | 1,766 |
| Net block and other assets | 2,993 | 3,190 | 3,362 | 3,499 | 3,588 | 3,615 |
| Debt | 1 | 1 | 1 | 1 | 1 | 1 |
| Equity | 3,631 | 4,216 | 4,877 | 5,624 | 6,468 | 7,422 |
| Balance check | 0 | (0) | (0) | (0) | (0) | (0) |
| Cash flow | ||||||
| From operations | 587 | 663 | 749 | 847 | 957 | |
| Investing (capex) | (279) | (264) | (241) | (207) | (160) | |
| Financing (dividends) | (45) | (51) | (57) | (65) | (73) | |
| Net change in cash | 263 | 348 | 451 | 576 | 724 | |
| Free cash flow to equity | 308 | 399 | 509 | 640 | 797 | |
Other liabilities are held at their FY26 level, so the check tests only what the model moves: cash, working capital, net block and other assets, debt and equity. A non-zero check would mean the three statements no longer tie.
Scenarios side by side · ₹ per share
| Scenario | Template | Growth | Margin | Rate | Terminal | ₹ / share | vs CMP |
|---|---|---|---|---|---|---|---|
| Base · editing | DCF | 13% | 34.8% | 11.00% | 5% | ₹1,361 | (50.6)% |
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.